Morgan Stanley raised its price objective for Iridium, while Raymond James Financial restated its market perform rating, with MarketBeat providing consensus data.
1 report, 1 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley raised its price objective for Iridium, while Raymond James Financial restated its market perform rating, with MarketBeat providing consensus data.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
iridium
chemical element with symbol Ir and atomic number 77
-
Morgan Stanley
U.S. investment bank
-
Raymond James Financial
American Investment Bank and Financial Services Firm
Nothing else this week.
Related events
- Morgan Stanley provided analyst ratings and price targets for Steel Dynamics, whose stock trades on NASDAQ.
- MarketBeat, Royal Bank of Canada, and Raymond James Financial updated their ratings and price targets for CT Real Estate Investment Trust.
- MarketBeat is aggregating consensus ratings for Cytokinetics, while Bank of America provided a neutral rating and Morgan Stanley raised its target price.
- Raymond James Financial and Benchmark provided updated market performance and buy ratings for Malibu Boats.
- MarketBeat aggregates consensus rating data on Aegon, while Citigroup weighed in and Morgan Stanley downgraded the rating.